503 related articles for article (PubMed ID: 16356659)
1. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
[TBL] [Abstract][Full Text] [Related]
2. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility.
Fairbairn N; Small W; Shannon K; Wood E; Kerr T
Soc Sci Med; 2008 Sep; 67(5):817-23. PubMed ID: 18562065
[TBL] [Abstract][Full Text] [Related]
3. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
Kerr T; Small W; Moore D; Wood E
Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
[TBL] [Abstract][Full Text] [Related]
4. Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.
Petrar S; Kerr T; Tyndall MW; Zhang R; Montaner JS; Wood E
Addict Behav; 2007 May; 32(5):1088-93. PubMed ID: 16930849
[TBL] [Abstract][Full Text] [Related]
5. Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.
Wood RA; Wood E; Lai C; Tyndall MW; Montaner JS; Kerr T
Int J Drug Policy; 2008 Jun; 19(3):183-8. PubMed ID: 18367389
[TBL] [Abstract][Full Text] [Related]
6. Access to health and social services for IDU: the impact of a medically supervised injection facility.
Small W; Van Borek N; Fairbairn N; Wood E; Kerr T
Drug Alcohol Rev; 2009 Jul; 28(4):341-6. PubMed ID: 19594786
[TBL] [Abstract][Full Text] [Related]
7. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
Milloy MJ; Kerr T; Mathias R; Zhang R; Montaner JS; Tyndall M; Wood E
Am J Drug Alcohol Abuse; 2008; 34(4):499-509. PubMed ID: 18584579
[TBL] [Abstract][Full Text] [Related]
8. Do supervised injecting facilities attract higher-risk injection drug users?
Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
Kerr T; Marsh D; Li K; Montaner J; Wood E
Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
[TBL] [Abstract][Full Text] [Related]
10. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.
Small W; Shoveller J; Moore D; Tyndall M; Wood E; Kerr T
Qual Health Res; 2011 Jun; 21(6):743-56. PubMed ID: 21378259
[TBL] [Abstract][Full Text] [Related]
11. Identifying injection drug users at risk of nonfatal overdose.
Coffin PO; Tracy M; Bucciarelli A; Ompad D; Vlahov D; Galea S
Acad Emerg Med; 2007 Jul; 14(7):616-23. PubMed ID: 17554010
[TBL] [Abstract][Full Text] [Related]
12. Remission from drug dependence symptoms and drug use cessation among women drug users in puerto rico.
Warner LA; AlegrÃa M; Canino G
Arch Gen Psychiatry; 2004 Oct; 61(10):1034-41. PubMed ID: 15466677
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.
Wood E; Kerr T; Stoltz J; Qui Z; Zhang R; Montaner JS; Tyndall MW
Public Health; 2005 Dec; 119(12):1111-5. PubMed ID: 16214189
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with public injecting among users of Vancouver's supervised injection facility.
McKnight I; Maas B; Wood E; Tyndall MW; Small W; Lai C; Montaner JS; Kerr T
Am J Drug Alcohol Abuse; 2007; 33(2):319-25. PubMed ID: 17497555
[TBL] [Abstract][Full Text] [Related]
15. Employment among users of a medically supervised safer injection facility.
Richardson L; Wood E; Zhang R; Montaner J; Tyndall M; Kerr T
Am J Drug Alcohol Abuse; 2008; 34(5):519-25. PubMed ID: 18821450
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
Miller CL; Strathdee SA; Li K; Kerr T; Wood E
Am J Drug Alcohol Abuse; 2007; 33(4):527-36. PubMed ID: 17668338
[TBL] [Abstract][Full Text] [Related]
17. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
[TBL] [Abstract][Full Text] [Related]
18. Condom use among injection drug users accessing a supervised injecting facility.
Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
[TBL] [Abstract][Full Text] [Related]
19. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study.
Small W; Wood E; Lloyd-Smith E; Tyndall M; Kerr T
Drug Alcohol Depend; 2008 Nov; 98(1-2):159-62. PubMed ID: 18650034
[TBL] [Abstract][Full Text] [Related]
20. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
Andresen MA; Boyd N
Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
